December 7, 2020 Comments Off on Investor Alert: Organovo Holdings Inc.  Blog, Current Investigations

Investor Alert: Organovo Holdings Inc. 

Investor Alert: Organovo Holdings Inc., featured by top securities fraud attorneys, The White Law Group

Recovery of Investment Losses – Organovo Holdings Inc.

The White Law Group is investigating potential securities claims involving broker-dealers who may have unsuitably recommended Organovo Holdings Inc. to investors.

Organovo Holdings, Inc.(NASDAQ: ONVO),  a biotechnology company, reportedly develops bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture, according to MarketWatch. 

The company reportedly filed a form D to raise capital from investors in 2013. The total offering amount was purportedly $7,662,675, according to SEC filings.

According to a press release on October 21, 2019, an investor in shares of Organovo Holdings, Inc. filed a lawsuit against members of the board of directors of Organovo Holdings, Inc over alleged breaches of fiduciary duties.

The plaintiff alleges that disclosures made by Organovo and its Board of Directors in the Company’s proxy statement related to its 2019 annual meeting of stockholders are false and misleading, according to the press release.

Shares of Organovo Holdings, Inc. (NASDAQ: ONVO) declined from $4.99 per share in August 2016 to as low as $.024 per share on September 5, 2019. .

The company also reported that its Total Revenue declined from $4.6 million for the 12 months period that ended on March 31, 2018 declined to $3.09 million for the 12 months period that ended on March 31, 2019, and that its Net Loss over those time periods increased from $34.8 million to $26.63 million.

File a Claim against your Brokerage Firm – Recovery of Investment Losses

Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.

If a broker or brokerage firm makes an unsuitable investment recommendation or fails to adequately disclose the risks associated with an investment they may be found liable for investment losses in a FINRA arbitration claim. Fortunately, FINRA provides an arbitration forum for investors to resolve such disputes.

If you are concerned about your investment in Organovo Holdings Inc., you may be able to file a complaint against your brokerage firm. Please contact the securities attorneys at The White Law Group at 1-888-637-5510 for a free consultation. 

The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois. The firm represents investors throughout the country in claims against their brokerage firm.

For more information on the firm and its representation of investors, visit  www.WhiteSecuritiesLaw.com.

Comments are closed.